| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |